0000950170-24-010535.txt : 20240202 0000950170-24-010535.hdr.sgml : 20240202 20240202163022 ACCESSION NUMBER: 0000950170-24-010535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ketchum Steven B CENTRAL INDEX KEY: 0001289884 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 24591950 MAIL ADDRESS: STREET 1: 2483 EAST BAYSHORE ROAD STREET 2: SUITE 100 CITY: PALO ALTO STATE: CA ZIP: 94303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 ownership.xml 4 X0508 4 2024-01-31 0000897448 AMARIN CORP PLC\UK AMRN 0001289884 Ketchum Steven B C/O AMARIN PHARMA, INC. 440 US HIGHWAY 22 BRIDGEWATER NJ 08807 false true false false Chief Scientific Officer false Ordinary Shares 2024-01-31 4 M false 34567 A 654974 D Ordinary Shares 2024-01-31 4 F false 18871 1.24 D 636103 D Ordinary Shares 2024-01-31 4 M false 44933 A 681036 D Ordinary Shares 2024-01-31 4 F false 22316 1.24 D 658720 D Restricted Stock Unit 0.00 2024-01-31 4 M false 34567 0.00 D Ordinary Shares 34567 34566 D Restricted Stock Unit 0.00 2024-01-31 4 M false 44933 0.00 D Ordinary Shares 44933 89867 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. On February 4, 2022, the Reporting Person was granted 103,700 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (as amended, the "Plan"). These RSUs vest in three equal installments on each of January 31, 2023, January 31, 2024 and January 31, 2025. Not applicable Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. On February 21, 2023, the Reporting Person was granted 134,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. /s/ Tom Reilly, by power of attorney 2024-02-02